These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 6110958

  • 1. What we could do with an EBV vaccine.
    Lancet; 1981 Apr 04; 1(8223):759-61. PubMed ID: 6110958
    [No Abstract] [Full Text] [Related]

  • 2. Adoptive immunotherapy for EBV-associated malignancies.
    Lucas KG, Barrett JC.
    Cancer Treat Res; 1999 Apr 04; 101():203-32. PubMed ID: 10800651
    [No Abstract] [Full Text] [Related]

  • 3. Clinical consequences of Epstein-Barr virus infection and possible control by an anti-viral vaccine.
    Epstein MA, Morgan AJ.
    Clin Exp Immunol; 1983 Aug 04; 53(2):257-71. PubMed ID: 6309441
    [No Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus. Is it timely to discuss a vaccine?
    Biomedicine; 1978 Aug 04; 28(1):15-7. PubMed ID: 208671
    [No Abstract] [Full Text] [Related]

  • 5. Approaches to immunological control of virus-associated tumors in man: introductory remarks.
    Levine PH.
    Cancer Res; 1976 Feb 04; 36(2 pt 2):565-9. PubMed ID: 175916
    [No Abstract] [Full Text] [Related]

  • 6. [Vaccine from irradiated neoplasm material].
    Osterberg S.
    Lakartidningen; 1969 Jun 11; 66(24):2503-5. PubMed ID: 4895128
    [No Abstract] [Full Text] [Related]

  • 7. Vaccination against EB virus.
    Br Med J; 1976 Dec 18; 2(6050):1467-8. PubMed ID: 187278
    [No Abstract] [Full Text] [Related]

  • 8. Epstein-Barr virus--is it time to develop a vaccine program?
    Epstein MA.
    J Natl Cancer Inst; 1976 Apr 18; 56(4):697-700. PubMed ID: 176406
    [No Abstract] [Full Text] [Related]

  • 9. Epstein-Barr virus-associated cancers: aetiology and treatment.
    Lopes V, Young LS, Murray PG.
    Herpes; 2003 Dec 18; 10(3):78-82. PubMed ID: 14759340
    [Abstract] [Full Text] [Related]

  • 10. The clinical significance of immunological findings in Burkitt's lymphoma. (Epstein-Barr virus-associated antibodies/BCG treatment.
    Gunvén P.
    Hamatol Bluttransfus; 1974 Dec 18; 14():129-32. PubMed ID: 4375070
    [No Abstract] [Full Text] [Related]

  • 11. Immunologic markers for Epstein-Barr virus in the control of nasopharyngeal carcinoma and Burkitt lymphoma.
    Levine PH.
    Cancer Detect Prev Suppl; 1987 Dec 18; 1():217-23. PubMed ID: 2826001
    [Abstract] [Full Text] [Related]

  • 12. [Viruses and human cancers: fundamental aspects and hopes of prevention].
    de Thé G.
    C R Seances Soc Biol Fil; 1986 Dec 18; 180(3):249-61. PubMed ID: 3022897
    [No Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus (EBV). IV. Studies on experimental inactivated vaccine against human EBV infection.
    Pătraşcu IV, Tache M.
    Virologie; 1988 Dec 18; 39(1):29-33. PubMed ID: 2837001
    [Abstract] [Full Text] [Related]

  • 14. The Epstein-Barr Virus (EBV) in Burkitt's lymphoma and nasopharyngeal carcinoma.
    Henle W, Henle G.
    Ann Clin Lab Sci; 1974 Dec 18; 4(2):109-14. PubMed ID: 4362218
    [No Abstract] [Full Text] [Related]

  • 15. [EB virus-associated tumors-opportunistic B cell lymphoma, Burkitt's lymphoma, nasopharyngeal carcinoma].
    Mizuno F.
    Nihon Rinsho; 1989 Feb 18; 47(2):481-6. PubMed ID: 2542671
    [No Abstract] [Full Text] [Related]

  • 16. [Study on the effect of human herpesvirus 6 on replication of Epstein-Barr virus].
    Xia Q, Meng G, Ai Y.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Aug 18; 33(4):235-6. PubMed ID: 11717892
    [Abstract] [Full Text] [Related]

  • 17. Prospects of vaccines against cancer in man.
    Bey EM.
    S Afr Med J; 1978 Jul 29; 54(5):189-92. PubMed ID: 212839
    [Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus-targeted immunotherapy for nasopharyngeal carcinoma.
    Masmoudi A, Toumi N, Khanfir A, Kallel-Slimi L, Daoud J, Karray H, Frikha M.
    Cancer Treat Rev; 2007 Oct 29; 33(6):499-505. PubMed ID: 17544585
    [Abstract] [Full Text] [Related]

  • 19. A prototype vaccine to prevent Epstein-Barr virus-associated cancers.
    Epstein M.
    Chemioterapia; 1987 Jun 29; 6(2 Suppl):655-8. PubMed ID: 2855615
    [No Abstract] [Full Text] [Related]

  • 20. A strategy for specific targeting of therapeutic agents to tumour cells of virus-associated cancers.
    Evans TJ, Brooks L, Farrell PJ.
    Gene Ther; 1997 Mar 29; 4(3):264-7. PubMed ID: 9135741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.